Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.

Hemasphere · 2025 · PMC12626236 · PMID 41262124

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

borderline significanceP = 0.059so close (0.05 < p ≤ 0.1)

Neurotoxicity with prior CAR T was associated with worse PFS with borderline significance (HR 2.51 [95% Cl 1.01–6.23]; likelihood ratio test, P = 0.059).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.